lundi 1 février 2016

Onco Actu du 1er février 2016

1. Biologie

How predictable is cancer? [The Institute of Cancer Research]

3. Prévention

Fruit and veg 'could reduce breast cancer risk by one quarter' [The Telkegraph]

Don't risk skin cancer while chasing vitamin D boost, authorities warn [The Guardian]

3.3 Prévention - Vaccins

Sixty-Nine Cancer Centers Urge HPV Vaccination [The Cancer Letter]

4.10 Dép., diag. & prono. - FDA, EMA, NICE,...

Glossary - BEST (Biomarkers, EndpointS, and other Tools) Resource [NCBI Bookshelf]

4.12 Biopsies liquides

Avera Medical Group and Epic Sciences collaborate on cancer precision medicine clinical trials [Epic Sciences]

4.9 Dép., diag. & prono. - Sein

DNA in healthy breast tissue may indicate cancer risk [UPI]

5. Traitements

Proton beam therapy has fewer harsh side effects, according to child cancer study [The Guardian]

Proton beam cancer therapy 'effective with fewer side effects' [BBC News]

A Conversation about Cancer Nanotechnology [National Cancer Institute]

5.12 Immunothérapies

The synNotch solution: UCSF scientists engineer a next-gen T-cell immunotherapy [FierceBiotech Research]

Synthetic biologists aim for better cancer-fighting cells [STAT]

5.3 Traitements - FDA, EMA,...

Orphan Medicines in the EU: A 15-Year Review [RAPS]

5.3.4 Traitements - AMM (FDA, EMA)

Exelixis Announces European Medicines Agency Acceptance of Marketing Authorization Application for Cabozantinib as a Treatment for Advanced Renal Cell Carcinoma [Exelixis]

EMA fast-tracks treatment of multiple myeloma for approval in EU [EMA]

Exelixis Announces U.S. FDA Deems New Drug Application Sufficiently Complete and Grants Priority Review for Cabozantinib as a Treatment for Advanced Renal Cell Carcinoma [Exelixis]

Bristol-Myers Squibb and AbbVie Receive Positive CHMP Opinion for Investigational Antibody, Empliciti (elotuzumab), for the Treatment of Multiple Myeloma in Patients Who Have Received at Least One Prior Therapy [BMS]

6. Lutte contre les cancers

Drug Shortages Forcing Hard Decisions on Rationing Treatments [NY Times]

Germany’s excellence program gets good grades [Science]

An ethical way to choose which kids get chemo during a shortage? [Reuters]

6.10 Politiques

Precision Medicine: A One-Year Update [Medium]

Biden’s cancer bid exposes rift among researchers [Politico]

Big Pharma takes a beating on the Democrats' campaign trail [STAT]

Obama's 'Cancer Moonshot' Should Start With The Basics [Fortune]

6.11 Patients

Why are doctors so bad at telling patients they’re dying? [STAT]

Video Helps Prepare Patients to Participate in Cancer Trials [National Cancer Institute]

6.7 DMP, Big Data & applis

ASCO Encouraging Members to Have Their Practices Become CancerLinQ Early Adopters [ASCO]

6.9 Controverses

Texas Cancer Agency Names James Willson Top Science Officer [Xconomy]